Axogen
AXGN • NASDAQ
Axogen is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Michael D. Dale, with a market cap of $1.6B.
CEOMichael D. Dale
Next Earnings
Upcoming earnings announcement for Axogen
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.02
Revenue Estimate
$58.1M
Earnings History
Past 12 earnings reports for Axogen
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Q4 2025 | $0.07Est: $0.04 | +75.0% | $59.9MEst: $59.9M | +0.0% |  10-K |
| Oct 29, 2025 | Q3 2025 | $0.12Est: $0.03 | +300.0% | $60.1MEst: $57.0M | +5.5% | 10-Q |
| Aug 5, 2025 | Q2 2025 | $0.12Est: $0.02 | +500.0% | $56.7MEst: $52.7M | +7.5% | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.02Est: $0.02 | -200.0% | $48.6MEst: $48.4M | +0.4% | 10-Q |
| Feb 25, 2025 | Q4 2024 | $0.07Est: $0.04 | +75.0% | $49.4MEst: $49.4M | +0.0% | 10-K |
| Nov 7, 2024 | Q3 2024 | $0.07Est: $0.01 | +600.0% | $48.6MEst: $47.1M | +3.3% | 10-Q |
| Aug 8, 2024 | Q2 2024 | $0.05Est: -$0.04 | +225.0% | $47.9MEst: $43.4M | +10.4% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.06Est: -$0.07 | +14.3% | $41.4MEst: $42.0M | -1.4% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.06Est: -$0.10 | +40.0% | $42.9MEst: $41.7M | +3.0% | 10-K |
| Nov 7, 2023 | Q3 2023 | $0.01Est: -$0.06 | +116.7% | $41.3MEst: $40.5M | +2.0% | — |
| Aug 7, 2023 | Q2 2023 | -$0.03Est: -$0.15 | +80.0% | $38.2MEst: $39.4M | -3.2% | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.10Est: -$0.14 | +28.6% | $36.7MEst: $35.4M | +3.7% | — |